Culver City, Calif. – May 23, 2017 — NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced the appointment of Ronald A. Louks as its Chief Operating Officer.
“Ron brings senior level leadership and excellent experience, gained at some of the most highly regarded and well recognized companies in the world, including Blackberry, HTC and Sony Ericsson,” said Patrick Soon-Shiong, M.D., Chief Executive Officer and Chairman of NantHealth. “His credentials and experience as an operations leader who can drive innovation in global organizations speak for themselves. Ron will oversee the company’s global operations; he has expertise in launching new products globally, mergers and acquisitions, supply chain, sales operations, marketing, manufacturing, e-commerce, retail, quality control, information technology and growing early stage businesses. We welcome Ron and he will play an instrumental role to build and execute our global strategy and drive the company’s growing market share and international expansion.”
Prior to joining NantHealth, Louks, served as President of Devices & Emerging Solutions at BlackBerry Limited. Earlier, Louks served as Chief Executive Officer of the OpenNMS Group, the world’s largest open-source network management company. Before that, he was Chief Strategy Officer for HTC Corporation, where he was also responsible for driving new strategic initiatives and all new technologies including M&A responsibilities. Previous to this, he held a number of senior leadership positions at Sony Ericsson, most recently serving as its Chief Technology Officer. He has driven innovation and launched new products, commercializing them, and shipped more than 250 million mobile phones globally, hundreds of millions of accessories, in addition to hundreds of commercial software products.
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth’s unique systems-based approach to personalized healthcare applies novel diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with large-scale, real-time biometric signal and phenotypic data to track patient outcomes and deliver precision medicine. For nearly a decade, NantHealth has developed an adaptive learning system, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets billions of molecular, clinical, operational and financial data points derived from novel and traditional sources, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time. For more information please visit www.nanthealth.com.